Teclistamab (BCMAxCD3) Journey from Discovery to Filing

Time: 9:30 am
day: Day Two

Details:

  • Telling the story of a BCMA-targeted drug developmental success from bench to bedside
  • Exploring the latest exciting data and predicting gaps and future directions for space

Speakers: